![]() |
市场调查报告书
商品编码
1679224
2030 年鼻喷雾包装市场预测:按容器类型、材料、药物类型、剂型、应用、最终用户和地区进行的全球分析Nasal Spray Packaging Market Forecasts to 2030 - Global Analysis By Container Type (Pressurized Containers and Pump Bottles), Material, Drug Type, Dosage Form, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球鼻喷剂包装市场价值为 16.918 亿美元,预计到 2030 年将达到 25.675 亿美元,预测期内的复合年增长率为 7.2%。
用于透过鼻腔注入液体药物或溶液的专门容器和输送系统称为鼻喷雾包装。它由金属、玻璃或塑胶製成的瓶子和泵组成。这些包装选项提高了使用者的便利性,同时确保了准确的剂量、无菌性和防止污染。它广泛用于医疗和非处方药物、鼻充血药、过敏缓解剂和其他鼻窦治疗。
根据美国过敏、气喘和免疫学学会(AAAAI)的数据,全球过敏性鼻炎的盛行率估计在人口的10%至30%之间。
呼吸系统疾病盛行率上升
过敏性鼻炎、慢性鼻窦炎和气喘等呼吸系统疾病的发生率不断上升,是鼻喷雾包装市场发展的主要驱动因素。据卫生组织称,过敏性鼻炎等疾病在世界各地越来越常见,对有效、便捷的治疗方法的需求巨大。鼻腔喷剂可将药物直接有效地输送到患处,从而快速缓解症状并提高患者的依从性。此外,人口老化使得人们更容易患上呼吸系统疾病,这也进一步扩大了消费群。
先进封装成本高昂
要遵守 FDA 和 EMA 等机构制定的严格监管标准,需要在研究、开发和品质保证方面投入大量资金,这给中小型製造商带来了特别的负担。此外,特种塑胶、特殊涂层玻璃和智慧包装组件等创新材料的高成本限制了它们的应用,尤其是在价格敏感的市场中。实施此类先进解决方案的财务负担可能会限制市场成长。
非侵入性药物输送的需求不断增加
人们对非侵入性药物输送方法的日益偏好为鼻腔喷雾剂包装市场提供了巨大的机会。口服药物对于患有吞嚥障碍的患者,尤其是50岁或以上患有吞嚥障碍的患者来说是一个挑战。鼻喷雾提供了一种无痛、易于使用的解决方案,可以避免这些挑战,提高患者的依从性和治疗效果。这些不断变化的偏好正在加速鼻内给药系统的采用和发展,为包装製造商创造了巨大的成长机会。
仿冒品品
仿冒品、劣质鼻喷雾的盛行对鼻喷雾包装市场构成了重大威胁。这些仿冒品不仅对正品製造商造成经济损失,还会对消费者造成严重的健康风险,包括过敏反应、噁心和呕吐。儘管感应封条、NFC 标籤、奈米条码、序列化和区块链解决方案等防伪技术取得了进步,但造假者通常会在两到三年内找到绕过这些系统的方法。这要求医药包装公司进行频繁且昂贵的升级,从而带来持续的挑战,需要持续的创新和投资来维持产品完整性和消费者安全。
COVID-19 疫情以多种方式影响了鼻喷雾包装市场。最初,由于重点转向疫苗开发,创新放缓。然而,与 COVID-19 相关的新病毒株和呼吸道症状的出现重新引起了人们对鼻喷雾产品的兴趣。製药公司已经开始开发抗病毒鼻喷雾,一些公司在减少病毒量方面已显示出良好的效果。这一趋势为包装製造商创造了机会,他们与医疗保健公司合作开发不会干扰药品的安全、无菌包装解决方案。这场疫情最终加速了对鼻喷雾产品及其包装的需求。
预测期内泵瓶市场预计将成为最大的市场
由于其经济的价格和广泛的药物使用适用性,预计在预测期内泵瓶将占据最大的市场占有率。这些容器提供精确的剂量控制、患者的便利性以及与非加压式鼻喷雾配方的兼容性。它的受欢迎程度源于其易于使用的设计、提供一致剂量的能力以及与多种药物製剂的兼容性,包括生理食盐水、类固醇和抗组织胺药物鼻喷雾。消费者对易于使用的药物输送系统的偏好增加,进一步支持了这一领域的成长。
预计预测期内粉末部分将以最高的复合年增长率成长。
由于粉末鼻腔给药技术的重大进步,预计预测期内粉末部分将见证最高成长率。像 Hovione 这样的公司正在透过推出创新的粉末输送设备来提高鼻内治疗的效果,从而扩大其产能。与液体喷雾剂相比,粉末製剂具有多种优势,包括更好的稳定性、更长的保质期以及潜在改善的药物吸收。此外,利用鼻喷粉给药系统的新冠疫苗的开发也加速了该领域的研究和投资。
预计预测期内北美地区将占据鼻腔喷雾包装市场最大的市场占有率。这一优势得益于呼吸系统疾病的高发性、先进的医疗保健基础设施以及大型製药公司的强大影响力。严格的监管标准、较高的消费者意识以及对药品包装创新的大量投资进一步加强了北美的领导地位。
在预测期内,预计亚太地区鼻喷雾包装市场将呈现最高的复合年增长率,这归因于医疗保健行业的不断扩大、呼吸系统疾病患病率的不断上升以及中国、印度和日本等国家的可支配收入不断增加等多种因素。庞大的人口数量、对鼻喷雾益处的认识不断提高以及医疗保健服务的改善提供了巨大的成长机会。此外,药物研发的技术创新和政府对医疗保健基础设施建设的资金增加也促进了该地区的成长。
According to Stratistics MRC, the Global Nasal Spray Packaging Market is accounted for $1691.8 million in 2024 and is expected to reach $2567.5 million by 2030 growing at a CAGR of 7.2% during the forecast period. Specialized containers and delivery systems intended to store and distribute liquid drugs or solutions via the nasal route are referred to as nasal spray packaging. It consists of bottles and pumps composed of metal, glass, or plastic. These package options improve user ease while guaranteeing accurate dosage, sterility, and contamination protection. In both medical and over-the-counter applications, they are extensively utilized for medications, decongestants, allergy alleviation, and other nasal therapies.
According to the American Academy of Allergy, Asthma & Immunology (AAAAI), the global prevalence of allergic rhinitis is estimated to be between 10% and 30% of the population.
Rising prevalence of respiratory diseases
The increasing prevalence of respiratory diseases such as allergic rhinitis, chronic sinusitis, and asthma is a significant driver for the nasal spray packaging market. According to health organizations, conditions like allergic rhinitis have become increasingly common worldwide, creating a substantial demand for effective and convenient treatment options. Nasal sprays offer direct and efficient medication delivery to affected areas, providing quick relief and improving patient compliance. Additionally, the aging population, which is more susceptible to respiratory conditions, further expands the consumer base.
High cost of advanced packaging materials
Compliance with stringent regulatory standards established by bodies such as the FDA and EMA requires substantial investment in research, development, and quality assurance, which can be particularly burdensome for smaller manufacturers. Additionally, innovative materials like specialized plastics, glass with specific coatings, and smart packaging components come at premium prices, limiting their adoption, especially in price-sensitive markets. The financial burden of implementing these advanced solutions can restrict market growth.
Growing demand for non-invasive drug delivery
The growing preference for non-invasive drug delivery methods presents a significant opportunity for the nasal spray packaging market. Oral medications pose challenges for patients with swallowing difficulties, particularly among older populations where dysphagia affects of people over 50 years of age. Nasal sprays offer a painless, easy-to-use solution that bypasses these challenges, improving patient compliance and treatment outcomes. This shift in preference is accelerating the adoption and development of nasal drug delivery systems, creating substantial growth opportunities for packaging manufacturers.
Counterfeit and substandard products
The proliferation of counterfeit and substandard nasal spray products poses a significant threat to the nasal spray packaging market. These fake products not only result in financial losses for legitimate manufacturers but also present serious health risks to consumers, including allergic reactions, nausea, and vomiting. Despite advancements in anti-counterfeiting technologies such as induction seals, NFC tags, nano barcodes, serialization, and blockchain solutions, counterfeiters typically find ways to bypass these systems within two to three years. This necessitates frequent and costly upgrades for pharmaceutical packaging companies, creating an ongoing challenge that requires continuous innovation and investment to maintain product integrity and consumer safety.
The COVID-19 pandemic had mixed effects on the nasal spray packaging market. Initially, it slowed innovations as focus shifted to vaccine development. However, the emergence of new virus strains and respiratory symptoms associated with COVID-19 created renewed interest in nasal spray products. Pharmaceutical companies began developing antiviral nasal sprays, with some showing promising results in reducing viral load. This trend created business opportunities for packaging manufacturers, who collaborated with healthcare companies to develop safe, sterile packaging solutions that wouldn't interfere with formulations. The pandemic ultimately accelerated demand for nasal spray products and their packaging.
The pump bottles segment is expected to be the largest during the forecast period
The pump bottles segment is expected to account for the largest market share during the forecast period due to their economic price point and wide drug usage compatibility. These containers offer precise dosage control, convenience for patients, and suitability for non-pressurized nasal spray formulations. Their popularity stems from their user-friendly design, ability to deliver consistent doses, and compatibility with various drug formulations, including saline, steroid, and antihistamine nasal sprays. This segment's growth is further supported by increasing consumer preference for easy-to-use medication delivery systems.
The powder segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the powder segment is predicted to witness the highest growth rate due to significant advancements in powder nasal delivery technologies. Companies like Hovione have expanded their capabilities by introducing innovative powder delivery devices that enhance the efficacy of intranasal treatments. Powder formulations offer several advantages over liquid sprays, including better stability, longer shelf life, and potentially improved drug absorption. Additionally, the development of COVID-19 vaccines utilizing nasal powder delivery systems has accelerated research and investment in this segment.
During the forecast period, the North America region is expected to hold the largest market share in the nasal spray packaging market. This dominance is attributed to the high prevalence of respiratory diseases, advanced healthcare infrastructure, and strong presence of major pharmaceutical companies. North America's leadership is further strengthened by stringent regulatory standards, high consumer awareness, and significant investment in pharmaceutical packaging innovations.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR in the nasal spray packaging market driven by several factors, including the region's expanding healthcare sector, increasing prevalence of respiratory diseases, and rising disposable incomes in countries like China, India, and Japan. The large population base, coupled with growing awareness about the benefits of nasal sprays and improving access to healthcare services, presents significant growth opportunities. Additionally, technological innovations in drug discovery and increased government funding for healthcare infrastructure development are contributing to the region's accelerated growth.
Key players in the market
Some of the key players in Nasal Spray Packaging Market include AptarGroup, Gerresheimer, Berry Global, Amcor, Bormioli Pharma, SGD Pharma, West Pharmaceutical, Coster Tecnologie, Nolato, Silgan Dispensing, Weener Plastics, Nemera, Medspray, Aero Pump, URSATEC and Richmond Containers.
In March 2024, Bormioli Pharma, a leading international manufacturer of pharmaceutical packaging and medical devices, today announced a significant increase of 47% in its North American sales for 2023. This notable growth is a direct result of the company's rapidly evolving infrastructure and expanded capacity, tailored to meet the unique demands of the North American pharmaceutical market, including an increased need for pharmaceutical glass vials.
In June 2023, Corning Incorporated and SGD Pharma announced a joint venture that includes the opening of a new glass tubing facility to expand pharmaceutical manufacturing in India and allows SGD Pharma to adopt Corning's Velocity(R) Vial technology platform.Combining SGD Pharma's vial-converting expertise with Corning's proprietary glass-coating technology, the collaboration will enhance vial quality, improve filling-line productivity, and speed the global delivery of injectable treatments.
In January 2023, Aptar Pharma, part of AptarGroup, Inc. a global leader in drug delivery systems, services and active material science solutions, today announces the launch of APF Futurity, its first metal-free, multidose nasal spray pump developed to deliver nasal saline and other comparable over-the-counter (OTC) formulations.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.